Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Victor Aquino, MD
Simmons Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital
Montreal, Quebec, Canada
- University of Alabama Comprehensive Cancer Center
Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- University of California San Diego Cancer Center
La Jolla, California, United States
- Lucile Packard Children'S Hospital at Stanford
Palo Alto, California, United States
- Sylvester Cancer Center, University of Miami
Miami, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Children'S Memorial Hospital, Chicago
Chicago, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Floating Hospital for Children
Boston, Massachusetts, United States
- Children'S Hospital of Michigan
Detroit, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Cardinal Glennon Children'S Hospital
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- State University of New York - Upstate Medical University
Syracuse, New York, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Saint Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Simmons Cancer Center - Dallas
Dallas, Texas, United States
- Cook Children'S Medical Center - Fort Worth
Fort Worth, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- Midwest Children'S Cancer Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 1998
- Primary completion
- 30 Jun 2003
- Completion
- —
- Last update posted
- 5 Feb 2013
- Registered enrollment
- 12
- Registry id
- NCT00003288
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.